|
|
Posted July 10, 2008
by
|
New York, New York
![]() |
This iReport is part of an assignment:
Keeping healthy, keeping fit |
Osteoporosis Drug FDA Approved To Prevent New Fractures
The U.S. Food and Drug Administration (FDA) has approved a new once-a-month dose of Actonel, making it the only oral once-a-month osteoporosis therapy approved to help prevent both spinal and non-spinal fractures in postmenopausal women.
The new once-a-month dose is now available for patients seeking the fracture protection of Actonel in the convenience of one monthly pill. In addition to being approved to help protect the spine from fractures, Actonel is also approved to help prevent non-spinal fractures, measured as a group, namely the hip, wrist, collar bone, arm, pelvis, and leg.
- TAGS:
- health,
- fitness,
- osteoporosis,
- actonel,
- drugs,
- fractures,
- women,
- post,
- menopausel
- GROUPS:
What do you think of this story?
iReport welcomes a lively discussion, so comments on iReports are not pre-screened before they post. See the iReport community guidelines for details about content that is not welcome on iReport.




Comments